Journal
MAYO CLINIC PROCEEDINGS
Volume 77, Issue 11, Pages 1176-1181Publisher
ELSEVIER SCIENCE INC
DOI: 10.4065/77.11.1176
Keywords
-
Categories
Ask authors/readers for more resources
Objective: To evaluate our results using photodynamic therapy (PDT) for the treatment of dysplasia or superficial cancer (T1 NO MO) in patients with Barrett esophagus. Patients and Methods: We retrospectively reviewed our clinical experience with 48 patients (34 patients with high-grade dysplasia and 14 patients with superficial cancer in Barrett esophagus) who had been referred for PDT. Initial evaluation included computed tomography and standard and high-frequency catheter-endosonography. Follow-up endoscopy was performed 4 to 6 weeks after Follow PDT with ablation of any residual glandular mucosa, using the argon plasma coagulator. Patients were then followed up indefinitely every 3 to 6 months with computed tomography, endosonography, and endoscopic surveillance. Results: The median series follow-up was 18.5 months (range, 1-56 months). Apparent complete photoablation of Barrett mucosa and/or superficial neoplasm was documented in 47 of 48 cases. Complications included symptomatic strictures (11 patients), photosensitivity (7 patients), atrial fibrillation (1 patient) or recurrent congestive heart failure (1 patient), and self-limited esophageal perforation (1 patient). Failure to ablate T1 NO MO adenocarcinoma occurred in 1 patient. Conclusions: Porfimer sodium PDT appears to eradicate dysplastic Barrett mucosa and neoplasia. These results are promising; however, long-term studies are needed to document the efficacy of PDT in reducing the morbidity and mortality in such patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available